{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:40:24Z","timestamp":1792896024954,"version":"4.5.0"},"reference-count":45,"publisher":"American Association for Cancer Research (AACR)","issue":"7","license":[{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Glioblastoma (GBM) is the most common malignant primary brain tumor and remains incurable. Previous work has shown that systemic administration of Decitabine (DAC) induces sufficient expression of cancer-testis antigens (CTA) in GBM for targeting by adoptive T-cell therapy in vivo. However, the mechanisms by which DAC enhances immunogenicity in GBM remain to be elucidated. Using New York esophageal squamous cell carcinoma 1 (NY-ESO-1) as a representative inducible CTA, we demonstrate in patient tissue, immortalized glioma cells, and primary patient-derived gliomaspheres that basal CTA expression is restricted by promoter hypermethylation in gliomas. DAC treatment of glioma cells specifically inhibits DNA methylation silencing to render NY-ESO-1 and other CTA into inducible tumor antigens at single-cell resolution. Functionally, NY-ESO-1 T-cell receptor\u2013engineered effector cell targeting of DAC-induced antigen in primary glioma cells promotes specific and polyfunctional T-cell cytokine profiles. In addition to induction of CTA, DAC concomitantly reactivates tumor-intrinsic human endogenous retroviruses, interferon response signatures, and MHC-I. Overall, we demonstrate that DAC induces targetable tumor antigen and enhances T-cell functionality against GBM, ultimately contributing to the improvement of targeted immune therapies in glioma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>This study dissects the tumor-intrinsic epigenetic and transcriptional mechanisms underlying enhanced T-cell functionality targeting decitabine-induced cancer-testis antigens in glioma. Our findings demonstrate concomitant induction of tumor antigens, reactivation of human endogenous retroviruses, and stimulation of interferon signaling as a mechanistic rationale to epigenetically prime human gliomas to immunotherapeutic targeting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-23-0566","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T10:48:34Z","timestamp":1718016514000},"page":"1834-1849","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Epigenetic Induction of Cancer-Testis Antigens and Endogenous Retroviruses at Single-Cell Level Enhances Immune Recognition and Response in Glioma"],"prefix":"10.1158","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7473-3095","authenticated-orcid":false,"given":"Thomas J.","family":"Lai","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6592-1156","authenticated-orcid":false,"given":"Lu","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0807-2506","authenticated-orcid":false,"given":"Kevin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4680-1359","authenticated-orcid":false,"given":"Terry J.","family":"Prins","sequence":"additional","affiliation":[{"name":"Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5854-7814","authenticated-orcid":false,"given":"Janet","family":"Treger","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5322-2270","authenticated-orcid":false,"given":"Tie","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1332-3696","authenticated-orcid":false,"given":"Matthew Z.","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4919-9159","authenticated-orcid":false,"given":"David A.","family":"Nathanson","sequence":"additional","affiliation":[{"name":"Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. 3"},{"name":"Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California. 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4053-0052","authenticated-orcid":false,"given":"Linda M.","family":"Liau","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. 1"},{"name":"Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. 3"},{"name":"Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California. 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7265-2986","authenticated-orcid":false,"given":"Albert","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. 2"},{"name":"UCLA Neuro-Oncology Program, University of California, Los Angeles, Los Angeles, California. 4"},{"name":"Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California. 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6282-6583","authenticated-orcid":false,"given":"Robert M.","family":"Prins","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. 1"},{"name":"Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. 3"},{"name":"Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California. 5"},{"name":"Parker Institute for Cancer Immunotherapy, San Francisco, California. 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2809-3061","authenticated-orcid":false,"given":"Richard G.","family":"Everson","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. 1"},{"name":"Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California. 5"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2024,7,26]]},"reference":[{"key":"2025032818073672700_bib1","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.3390\/ijms23137046","article-title":"Immunotherapy in glioblastoma: current approaches and future perspectives","volume":"23","author":"Sener","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025032818073672700_bib2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3389\/fimmu.2020.00835","article-title":"Single-cell Atlas reveals complexity of the immunosuppressive microenvironment of initial and recurrent glioblastoma","volume":"11","author":"Fu","year":"2020","journal-title":"Front Immunol"},{"key":"2025032818073672700_bib3","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.cell.2020.04.055","article-title":"Single-cell mapping of human brain cancer reveals tumor-specific instruction of tissue-invading leukocytes","volume":"181","author":"Friebel","year":"2020","journal-title":"Cell"},{"key":"2025032818073672700_bib4","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3390\/cells12060926","article-title":"Biology of cancer-testis antigens and their therapeutic implications in cancer","volume":"12","author":"Nin","year":"2023","journal-title":"Cells"},{"key":"2025032818073672700_bib5","doi-asserted-by":"crossref","first-page":"101133","DOI":"10.1016\/j.xcrm.2023.101133","article-title":"Phase 1 clinical trial to assess safety and efficacy of NY-ESO-1-specific TCR T cells in HLA-A*02:01 patients with advanced soft tissue sarcoma","volume":"4","author":"Pan","year":"2023","journal-title":"Cell Rep Med"},{"key":"2025032818073672700_bib6","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00262-015-1731-3","article-title":"A phase I trial combining decitabine\/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma","volume":"64","author":"Krishnadas","year":"2015","journal-title":"Cancer Immunol Immunother"},{"key":"2025032818073672700_bib7","doi-asserted-by":"crossref","first-page":"107889","DOI":"10.1016\/j.intimp.2021.107889","article-title":"A novel era of cancer\/testis antigen in cancer immunotherapy","volume":"98","author":"Meng","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"2025032818073672700_bib8","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1158\/2159-8290.CD-18-0442","article-title":"Tumor antigen escape from CAR T-cell therapy","volume":"8","author":"Majzner","year":"2018","journal-title":"Cancer Discov"},{"key":"2025032818073672700_bib9","doi-asserted-by":"crossref","first-page":"636","DOI":"10.18632\/oncotarget.950","article-title":"Expression of cancer\/testis antigens is correlated with improved survival in glioblastoma","volume":"4","author":"Freitas","year":"2013","journal-title":"Oncotarget"},{"key":"2025032818073672700_bib10","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/1479-5876-9-192","article-title":"Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas\/Fas ligand pathway","volume":"9","author":"Konkankit","year":"2011","journal-title":"J Transl Med"},{"key":"2025032818073672700_bib11","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1093\/neuonc\/noac107","article-title":"Decitabine increases neoantigen and cancer testis antigen expression to enhance T-cell-mediated toxicity against glioblastoma","volume":"24","author":"Ma","year":"2022","journal-title":"Neuro Oncol"},{"key":"2025032818073672700_bib12","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1002\/ijc.23407","article-title":"The DNA demethylating agent 5-aza-2\u2032-deoxycytidine activates NY-ESO-1 antigenicity in orthotopic human glioma","volume":"122","author":"Natsume","year":"2008","journal-title":"Int J Cancer"},{"key":"2025032818073672700_bib13","doi-asserted-by":"crossref","first-page":"e0162105","DOI":"10.1371\/journal.pone.0162105","article-title":"Decitabine treatment of glioma-initiating cells enhances immune recognition and killing","volume":"11","author":"Riccadonna","year":"2016","journal-title":"PLoS One"},{"key":"2025032818073672700_bib14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/neuonc\/nov153","article-title":"Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma","volume":"18","author":"Everson","year":"2016","journal-title":"Neuro Oncol"},{"key":"2025032818073672700_bib15","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.4049\/jimmunol.180.9.6116","article-title":"Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions","volume":"180","author":"Robbins","year":"2008","journal-title":"J Immunol"},{"key":"2025032818073672700_bib16","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1182\/blood-2018-01-828343","article-title":"Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL","volume":"132","author":"Rossi","year":"2018","journal-title":"Blood"},{"key":"2025032818073672700_bib17","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/bioinformatics\/18.11.1427","article-title":"MethPrimer: designing primers for methylation PCRs","volume":"18","author":"Li","year":"2002","journal-title":"Bioinformatics"},{"key":"2025032818073672700_bib18","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.18632\/oncotarget.679","article-title":"Reactivation of codogenic endogenous retroviral (ERV) envelope genes in human endometrial carcinoma and prestages: emergence of new molecular targets","volume":"3","author":"Strissel","year":"2012","journal-title":"Oncotarget"},{"key":"2025032818073672700_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat Biotechnol"},{"key":"2025032818073672700_bib20","doi-asserted-by":"crossref","first-page":"e169314","DOI":"10.1172\/JCI169314","article-title":"Immune checkpoint blockade induces distinct alterations in the microenvironments of primary and metastatic brain tumors","volume":"133","author":"Sun","year":"2023","journal-title":"J Clin Invest"},{"key":"2025032818073672700_bib21","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","article-title":"Minfi: a flexible and comprehensive bioconductor package for the analysis of infinium DNA methylation microarrays","volume":"30","author":"Aryee","year":"2014","journal-title":"Bioinformatics"},{"key":"2025032818073672700_bib22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat Methods"},{"key":"2025032818073672700_bib23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq\u2014a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"2025032818073672700_bib24","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2025032818073672700_bib25","first-page":"100141","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"2025032818073672700_bib26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"2025032818073672700_bib27","doi-asserted-by":"crossref","first-page":"637981","DOI":"10.3389\/fonc.2021.637981","article-title":"Identification of differentially expressed human endogenous retrovirus families in human leukemia and lymphoma cell lines and stem cells","volume":"11","author":"Engel","year":"2021","journal-title":"Front Oncol"},{"key":"2025032818073672700_bib28","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","article-title":"TCGAbiolinks: an R\/bioconductor package for integrative analysis of TCGA data","volume":"44","author":"Colaprico","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2025032818073672700_bib29","doi-asserted-by":"crossref","first-page":"D816","DOI":"10.1093\/nar\/gkn673","article-title":"CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens","volume":"37","author":"Almeida","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"2025032818073672700_bib30","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/s41416-020-0814-x","article-title":"IDH mutation in glioma: molecular mechanisms and potential therapeutic targets","volume":"122","author":"Han","year":"2020","journal-title":"Br J Cancer"},{"key":"2025032818073672700_bib31","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N Engl J Med"},{"key":"2025032818073672700_bib32","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1158\/2326-6066.CIR-13-0029","article-title":"NY-ESO-1 expression in meningioma suggests a rationale for new immunotherapeutic approaches","volume":"1","author":"Baia","year":"2013","journal-title":"Cancer Immunol Res"},{"key":"2025032818073672700_bib33","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jocn.2011.10.008","article-title":"Cancer-testis and melanocyte-differentiation antigen expression in malignant glioma and meningioma","volume":"19","author":"Syed","year":"2012","journal-title":"J Clin Neurosci"},{"key":"2025032818073672700_bib34","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1002\/cncr.23463","article-title":"Evolution of decitabine development: accomplishments, ongoing investigations, and future strategies","volume":"112","author":"Jabbour","year":"2008","journal-title":"Cancer"},{"key":"2025032818073672700_bib35","first-page":"592","article-title":"Plasma and cerebrospinal fluid pharmacokinetics of 5-aza-2\u2032-deoxycytidine in rabbits and dogs","volume":"43","author":"Chabot","year":"1983","journal-title":"Cancer Res"},{"key":"2025032818073672700_bib36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0026-895X(25)14371-X","article-title":"Incorporation of 5-aza-2\u2032-deoxycytidine-5\u2032-triphosphate into DNA. Interactions with mammalian DNA polymerase alpha and DNA methylase","volume":"24","author":"Bouchard","year":"1983","journal-title":"Mol Pharmacol"},{"key":"2025032818073672700_bib37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"key":"2025032818073672700_bib38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41467-017-02630-w","article-title":"DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer","volume":"9","author":"Luo","year":"2018","journal-title":"Nat Commun"},{"key":"2025032818073672700_bib39","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nmeth.2967","article-title":"Bayesian approach to single-cell differential expression analysis","volume":"11","author":"Kharchenko","year":"2014","journal-title":"Nat Methods"},{"key":"2025032818073672700_bib40","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2025032818073672700_bib41","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.cell.2015.07.011","article-title":"Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses","volume":"162","author":"Chiappinelli","year":"2015","journal-title":"Cell"},{"key":"2025032818073672700_bib42","doi-asserted-by":"crossref","first-page":"905988","DOI":"10.3389\/fgene.2022.905988","article-title":"TLR3 serves as a novel diagnostic and prognostic biomarker and is closely correlated with immune microenvironment in three types of cancer","volume":"13","author":"Zou","year":"2022","journal-title":"Front Genet"},{"key":"2025032818073672700_bib43","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3390\/pathogens12020162","article-title":"Endogenous retroviruses as modulators of innate immunity","volume":"12","author":"Russ","year":"2023","journal-title":"Pathogens"},{"key":"2025032818073672700_bib44","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.aaf2807","article-title":"Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade","volume":"354","author":"Pauken","year":"2016","journal-title":"Science"},{"key":"2025032818073672700_bib45","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1126\/science.aae0491","article-title":"The epigenetic landscape of T cell exhaustion","volume":"354","author":"Sen","year":"2016","journal-title":"Science"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-23-0566\/3461273\/crc-23-0566.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/7\/1834\/3500970\/crc-23-0566.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/7\/1834\/3500970\/crc-23-0566.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T19:11:31Z","timestamp":1743189091000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/4\/7\/1834\/746714\/Epigenetic-Induction-of-Cancer-Testis-Antigens-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-23-0566","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.28688664","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109567","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109558.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109579","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109573.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380645.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109576.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109570.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380627","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380615","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380642.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380609","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109576","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109564","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380612","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380636","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688655","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380624","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688667","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380618","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109561","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380606","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109573","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109561.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688670","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380639.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380636.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380606.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109564.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109567.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380621","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688658","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380645","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380633","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380624.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688673","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380630.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380639","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688661","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380618.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109570","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109579.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380627.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27109558","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380633.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380609.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380612.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380630","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380615.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380621.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26380642","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688649","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.7368019","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.7368019.v2","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.7368019.v1","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,1]]}}}